Photoactivated Cell-killing Involving a Low Molecular Weight, Donor-acceptor Diphenylacetylene
Overview
Authors
Affiliations
Photoactivation of photosensitisers can be utilised to elicit the production of ROS, for potential therapeutic applications, including the destruction of diseased tissues and tumours. A novel class of photosensitiser, exemplified by , has been designed possessing a modular, low molecular weight and 'drug-like' structure which is bioavailable and can be photoactivated by UV-A/405 nm or corresponding two-photon absorption of near-IR (800 nm) light, resulting in powerful cytotoxic activity, ostensibly through the production of ROS in a cellular environment. A variety of cellular assays confirmed ROS formation and cytotoxic activity was exemplified irradiation and subsequent targeted destruction of specific areas of a zebrafish embryo.
The antibacterial activity of a photoactivatable diarylacetylene against Gram-positive bacteria.
Waite R, Adams C, Chisholm D, Sims C, Hughes J, Dias E Front Microbiol. 2023; 14:1243818.
PMID: 37808276 PMC: 10556703. DOI: 10.3389/fmicb.2023.1243818.
Koscak M, Pehar I, Bozinovic K, Kole G, Sobocanec S, Podgorski I Pharmaceutics. 2022; 14(11).
PMID: 36432689 PMC: 9696974. DOI: 10.3390/pharmaceutics14112499.
Cellular internalization mechanism of novel Raman probes designed for plant cells.
Midorikawa K, Tsuchiya K, Law S, Miyagi Y, Asai T, Iino T RSC Chem Biol. 2021; 1(4):204-208.
PMID: 34458759 PMC: 8341950. DOI: 10.1039/d0cb00128g.